Antipodean Advisors’s Clarivate CLVT Stock Holding History

Antipodean Advisors’s Portfolio CLVT Stock Details CLVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-375,000	Closed	-$8.82M	–	7
2021 Q4	$8.82M	Sell	375,000 -750,000	-67%	-$17.4M	3.62%	5
2021 Q3	$24.6M	Sell	1,125,000 -150,000	-12%	-$3.65M	6.98%	4
2021 Q2	$35.1M	Hold	1,275,000	–	–	9.67%	4
2021 Q1	$33.6M	Hold	1,275,000	–	–	10.4%	4
2020 Q4	$37.9M	Hold	1,275,000	–	–	10.64%	4
2020 Q3	$39.5M	Hold	1,275,000	–	–	14.46%	4
2020 Q2	$28.5M	Hold	1,275,000	–	–	13.14%	4
2020 Q1	$26.5M	Hold	1,275,000	–	–	24.42%	1
2019 Q4	$21.4M	Buy	1,275,000 +100,000	+9%	+$1.68M	12.25%	4
2019 Q3	$19.8M	Buy	1,175,000 +75,000	+7%	+$1.24M	16.53%	3
2019 Q2	$16.9M	Buy	1,100,000 +195,000	+22%	+$2.72M	20.58%	2
2019 Q1	$12.2M	Buy	+905,000	New	+$10.1M	8.64%	3

Other funds holding CLVT

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

PGH

Partners Group Holding Baar-Zug, Switzerland $1.35B AUM 27.53% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Atairos Group Bryn Mawr, Pennsylvania $1.22B AUM 38.2% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Antipodean Advisors's CLVT Position: Q1 2022 in Review

Antipodean Advisors sold out of Clarivate (CLVT) in Q1 2022, closing a stake of 375,000 shares — an estimated $8.82M sold.

Antipodean Advisors first reported a position in CLVT in Q1 2019 and held it in 12 quarters. The position peaked at $39.5M in Q3 2020. 285 funds tracked by Wall St. Rank hold CLVT as of Q1 2022.

Antipodean Advisors reported no remaining Clarivate position as of Q1 2022 after selling out during the quarter.
Antipodean Advisors sold 375,000 Clarivate shares in Q1 2022, an estimated $8.82M.
Antipodean Advisors first reported a position in Clarivate in Q1 2019 and held it in 12 quarters.
Antipodean Advisors's Clarivate position peaked at $39.5M in Q3 2020.
285 funds tracked by Wall St. Rank held Clarivate as of Q1 2022.

Based on Antipodean Advisors's 13F filing for Q1 2022, filed 16 May 2022.